{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:59:57Z","timestamp":1790312397487,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejvs.2023.08.045","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T02:13:38Z","timestamp":1692843218000},"page":"490-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cost Effectiveness of Early Endovenous Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis in the United Kingdom"],"prefix":"10.1016","volume":"67","author":[{"given":"Joseph B.","family":"Babigumira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0539-9156","authenticated-orcid":false,"given":"Solomon J.","family":"Lubinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2329-6193","authenticated-orcid":false,"given":"Anna L.","family":"Pouncey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2023.08.045_bib1","doi-asserted-by":"crossref","first-page":"k351","DOI":"10.1136\/bmj.k351","article-title":"Deep vein thrombosis","volume":"360","author":"Stubbs","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2023.08.045_bib2","series-title":"The Prevention of Venous Thromboembolism in Hospitalised Patients","year":"2005"},{"key":"10.1016\/j.ejvs.2023.08.045_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-149-10-200811180-00004","article-title":"Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis","volume":"149","author":"Kahn","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejvs.2023.08.045_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9343(01)00661-1","article-title":"Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?","volume":"110","author":"Douketis","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ejvs.2023.08.045_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pcad.2011.03.008","article-title":"Endovascular therapies to treat iliofemoral deep venous thrombosis","volume":"54","author":"Jenkins","year":"2011","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ejvs.2023.08.045_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1538-7836.2008.03002.x","article-title":"Determinants of health-related quality of life during the 2 years following deep vein thrombosis","volume":"6","author":"Kahn","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ejvs.2023.08.045_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00000658-200106000-00004","article-title":"Iliofemoral deep vein\u00a0thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting","volume":"233","author":"AbuRahma","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejvs.2023.08.045_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/ejvs.2002.1665","article-title":"Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. a randomised clinical trial","volume":"24","author":"Elsharawy","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2023.08.045_bib9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1538-7836.2009.03464.x","article-title":"Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency","volume":"7","author":"Enden","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ejvs.2023.08.045_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.211.1.r99ap4739","article-title":"Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry","volume":"211","author":"Mewissen","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.ejvs.2023.08.045_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","article-title":"Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial","volume":"379","author":"Enden","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2023.08.045_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jvsv.2017.04.018","article-title":"Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement","volume":"5","author":"Lin","year":"2017","journal-title":"J\u00a0Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.ejvs.2023.08.045_bib13","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/CIRCULATIONAHA.118.037425","article-title":"Endovascular thrombus removal for acute iliofemoral deep vein thrombosis","volume":"139","author":"Comerota","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2023.08.045_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1067\/mva.2000.105664","article-title":"Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life","volume":"32","author":"Comerota","year":"2000","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.08.045_bib15","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S2352-3026(15)00248-3","article-title":"Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial","volume":"3","author":"Haig","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ejvs.2023.08.045_bib16","first-page":"CD002783","article-title":"Thrombolysis for acute deep vein thrombosis","volume":"1","author":"Watson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2023.08.045_bib17","first-page":"CD011536","article-title":"Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis","volume":"11","author":"Robertson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2023.08.045_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005659","article-title":"Cost-effectiveness of pharmacomechanical catheter-directed thrombolysis versus standard anticoagulation in patients with proximal deep vein thrombosis: results from the ATTRACT trial","volume":"12","author":"Magnuson","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ejvs.2023.08.045_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2146\/ajhp110241","article-title":"Quality of life and economic costs associated with postthrombotic syndrome","volume":"69","author":"Kachroo","year":"2012","journal-title":"Am J Health Syst Pharm"},{"issue":"20 Suppl 6","key":"10.1016\/j.ejvs.2023.08.045_bib20","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2146\/ajhp060388","article-title":"Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome","volume":"63","author":"MacDougall","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejvs.2023.08.045_bib21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1067\/mva.2001.113308","article-title":"Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study","volume":"33","author":"Heit","year":"2001","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.08.045_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/iwj.13000","article-title":"Measuring costs and quality of life for venous leg ulcers","volume":"16","author":"Barnsbee","year":"2019","journal-title":"Int Wound J"},{"key":"10.1016\/j.ejvs.2023.08.045_bib23","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/jth.12184","article-title":"Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis","volume":"11","author":"Enden","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ejvs.2023.08.045_bib24","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","article-title":"Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis","volume":"377","author":"Vedantham","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2023.08.045_bib25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40273-018-0672-z","article-title":"Discounting in economic evaluations","volume":"36","author":"Attema","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ejvs.2023.08.045_bib26","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"376","author":"Husereau","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2023.08.045_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00019053-199813040-00003","article-title":"An introduction to Markov modelling for economic evaluation","volume":"13","author":"Briggs","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ejvs.2023.08.045_bib28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jvsv.2018.08.002","article-title":"Meta-analysis and systematic review of percutaneous mechanical thrombectomy for lower extremity deep vein thrombosis","volume":"6","author":"Wang","year":"2018","journal-title":"J\u00a0Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.ejvs.2023.08.045_bib29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1212\/WNL.0000000000003681","article-title":"Temporal trends in early case-fatality rates in patients with intracerebral hemorrhage","volume":"88","author":"B\u00e9jot","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ejvs.2023.08.045_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.thromres.2012.07.011","article-title":"Trends in case fatality rate in pulmonary embolism according to stability and treatment","volume":"130","author":"Stein","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2023.08.045_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001155","article-title":"Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors","volume":"9","author":"Flinterman","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejvs.2023.08.045_bib32","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1160\/TH04-02-0075","article-title":"Treatment of venous thromboembolism with vitamin K antagonists: patients\u2019 health state valuations and treatment preferences","volume":"92","author":"Bossuyt","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejvs.2023.08.045_bib33","doi-asserted-by":"crossref","first-page":"A493","DOI":"10.1016\/j.jval.2014.08.1465","article-title":"Health state in patients with venous thromboembolism on conventional and non-VKA oral anticoagulants as assessed with the EQ-5D-5L questionnaire: PREFER in VTE registry","volume":"17","author":"Cohen","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.ejvs.2023.08.045_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002984","article-title":"Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study","volume":"3","author":"Enden","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejvs.2023.08.045_bib35","article-title":"Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK","volume":"6","author":"Clay","year":"2018","journal-title":"J\u00a0Mark Access Health Policy"},{"key":"10.1016\/j.ejvs.2023.08.045_bib36","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1161\/STROKEAHA.112.667204","article-title":"A\u00a0population-based study of hospital care costs during 5\u00a0years\u00a0after transient ischemic attack and stroke","volume":"43","author":"Luengo-Fernandez","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2023.08.045_bib37","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.3399\/bjgp15X684877","article-title":"Physician associates and GPs in primary care: a comparison","volume":"65","author":"Drennan","year":"2015","journal-title":"Br J\u00a0Gen Pract"},{"key":"10.1016\/j.ejvs.2023.08.045_bib50","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejvs.2020.05.006","article-title":"AngioJet pharmacomechanical thrombectomy and catheter directed thrombolysis vs. catheter directed thrombolysis alone for the treatment of iliofemoral deep vein thrombosis: a single centre retrospective cohort study","volume":"60","author":"Pouncey","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2023.08.045_bib51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","article-title":"The NICE cost-effectiveness threshold \u2013 what it is and what that means","volume":"26","author":"McCabe","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ejvs.2023.08.045_bib52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/00019053-200017050-00006","article-title":"Handling uncertainty in cost-effectiveness models","volume":"17","author":"Briggs","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ejvs.2023.08.045_bib53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jval.2012.04.014","article-title":"Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20146","volume":"15","author":"Briggs","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.ejvs.2023.08.045_bib54","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/SLA.0b013e3181d568db","article-title":"Recurrent deep vein thrombosis","volume":"251","author":"Labropoulos","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejvs.2023.08.045_bib55","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/01.RVI.0000228334.47073.C4","article-title":"Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes","volume":"17","author":"Kim","year":"2006","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ejvs.2023.08.045_bib56","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.amjsurg.2006.08.045","article-title":"Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis","volume":"192","author":"Lin","year":"2006","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejvs.2023.08.045_bib57","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.avsg.2018.01.104","article-title":"Catheter-directed thrombolysis versus pharmacomechanical thrombectomy for upper extremity deep venous thrombosis: a cost-effectiveness analysis","volume":"51","author":"Mahmoud","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.08.045_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2023.08.045_bib59","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jvsv.2022.02.013","article-title":"Interim outcomes of mechanical thrombectomy for deep vein thrombosis from the all-comer CLOUT registry","volume":"10","author":"Dexter","year":"2022","journal-title":"J\u00a0Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.ejvs.2023.08.045_bib60","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/j.1538-7836.2005.01648.x","article-title":"The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease","volume":"3","author":"Stain","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ejvs.2023.08.045_bib61","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00270-018-2016-y","article-title":"Just how attractive is the ATTRACT trial?","volume":"41","author":"O\u2019Sullivan","year":"2018","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588423007104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588423007104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:01:21Z","timestamp":1761048081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588423007104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1078588423007104"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2023.08.045","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost Effectiveness of Early Endovenous Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis in the United Kingdom","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2023.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}